Literature DB >> 24085254

Hippocampal and mesial temporal sclerosis in early-onset frontotemporal lobar degeneration versus Alzheimer's disease.

Aditi Joshi1, Edmond Teng, Kanida Tassniyom, Mario F Mendez.   

Abstract

Hippocampal sclerosis (HS) and mesial temporal sclerosis (MTS) may occur with frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD) as well as with normal aging. Prior studies suggest that HS/MTS may be more closely associated with FTLD but have not directly compared the prevalence and clinical characteristics of HS/MTS between neuropathologically confirmed early-onset (age ≤ 65) cohorts of FTLD and AD. We identified patients with early-onset FTLD (n = 136) and AD (n = 267) from National Alzheimer's Center Consortium databases and compared neuropathological and clinical data between these 2 groups. The FTLD group had a significantly higher prevalence of HS/MTS than that of the AD group. However, HS/MTS was associated with increasing age and memory impairment in the AD group but not in the FTLD group. These findings are consistent with the hypothesis that HS/MTS in FTLD occurs as part of the primary pathological process, rather than as a secondary, nonspecific effect of aging on memory and hippocampal function.

Entities:  

Keywords:  Alzheimer’s disease; behavioral variant frontotemporal dementia; frontotemporal lobar degeneration; hippocampal sclerosis

Mesh:

Year:  2013        PMID: 24085254      PMCID: PMC3947801          DOI: 10.1177/1533317513505134

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  20 in total

1.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

2.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

Authors:  D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

3.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

4.  Frontotemporal lobar degeneration without lobar atrophy.

Authors:  Keith A Josephs; Jennifer L Whitwell; Clifford R Jack; Joseph E Parisi; Dennis W Dickson
Journal:  Arch Neurol       Date:  2006-11

5.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

Review 6.  Hippocampal sclerosis dementia: a reappraisal.

Authors:  Alphonse Probst; Kirsten I Taylor; Markus Tolnay
Journal:  Acta Neuropathol       Date:  2007-07-17       Impact factor: 17.088

Review 7.  Frontotemporal dementia in elderly individuals.

Authors:  Atik Baborie; Tim D Griffiths; Evelyn Jaros; Parastoo Momeni; Ian G McKeith; David J Burn; G Keir; Andrew J Larner; David M Mann; Robert Perry
Journal:  Arch Neurol       Date:  2012-08

8.  Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.

Authors:  Andrew King; Safa Al-Sarraj; Claire Troakes; Bradley N Smith; Satomi Maekawa; Mariangela Iovino; Maria Grazia Spillantini; Christopher E Shaw
Journal:  Acta Neuropathol       Date:  2012-09-28       Impact factor: 17.088

9.  Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample.

Authors:  Chris Zarow; Michael W Weiner; William G Ellis; Helena Chang Chui
Journal:  Brain Behav       Date:  2012-06-26       Impact factor: 2.708

10.  Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy.

Authors:  Amy K Clippinger; Simon D'Alton; Wen-Lang Lin; Tania F Gendron; John Howard; David R Borchelt; Ashley Cannon; Yari Carlomagno; Paramita Chakrabarty; Casey Cook; Todd E Golde; Yona Levites; Laura Ranum; Patrick J Schultheis; Guilian Xu; Leonard Petrucelli; Naruhiko Sahara; Dennis W Dickson; Benoit Giasson; Jada Lewis
Journal:  Acta Neuropathol       Date:  2013-05-11       Impact factor: 17.088

View more
  1 in total

1.  Hippocampal sclerosis, hippocampal neuron loss patterns and TDP-43 in the aged population.

Authors:  Suvi R K Hokkanen; Sally Hunter; Tuomo M Polvikoski; Hannah A D Keage; Thais Minett; Fiona E Matthews; Carol Brayne
Journal:  Brain Pathol       Date:  2017-09-25       Impact factor: 6.508

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.